Correlation between the microinflammatory state and left ventricular structural and functional changes in maintenance haemodialysis patients

Shi,Lihua; Song,Jie; Zhang,Xiaodong; Li,Ying; Li,Hui

doi:10.3892/etm.2013.1131

Correlation between the microinflammatory state and left ventricular structural and functional changes in maintenance haemodialysis patients

Authors:
- Lihua Shi
- Jie Song
- Xiaodong Zhang
- Ying Li
- Hui Li
View Affiliations

Affiliations: Department of Nephrology, Affiliated Hospital of Logistics College of Chinese People's Armed Police Forces, Tianjin 300162, P.R. China
Published online on: May 28, 2013 https://doi.org/10.3892/etm.2013.1131
Pages: 532-536

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of this study was to examine the correlation between the microinflammatory state and structural and functional changes of the left ventricle in maintenance haemodialysis patients (MHD). In total, 48 MHD patients and 30 healthy volunteers participated in this study. The microinflammatory state was detected from high‑sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6) and tumour necrosis factor-α (TNF-α) levels determined by ELISA. The structure and function of the left ventricle was measured according to ultrasound cardiogram examination. The serum levels of hs-CRP, IL-6 and TNF-α in the MHD patients were higher compared with those in the controls (P<0.05). Furthermore, the measurements of the left atrial diameter (LAD), left venticular diameter (LVD), interventricular septal thickness (IVST), left ventricular posterior wall thickness (LVPWT) and the left ventricular mass index (LVMI) increased significantly and the left ventricular function (LVEF) was reduced. Correlation analysis demonstrated that the concentrations of hs-CRP, TNF-α and IL-6 correlated with the LVMI (P<0.05), but only hs-CRP correlated with the loss of function of the heart in the haemodialysis patients (P<0.05). The microinflammatory state may be closely associated with the structural and functional impairment of the heart in MHD patients.

View Figures

View References

1.	Schömig M, Eisenhandt A and Ritz E: The microinflammatory state of uremia. Blood Purif. 18:327–332. 2000.
2.	Kaysen GA: The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol. 12:1549–1557. 2001.PubMed/NCBI
3.	Tsirpanlis G, Chatzipanagiotou S and Nicolaou C: Microinflammation versus inflammation in chronic renal faiure patients. Kidney Int. 66:2093–2098. 2004. View Article : Google Scholar : PubMed/NCBI
4.	Memoli B, Postiglione L, Cianciaruso B, et al: Role of different dialysis membranes in the release of interleukin-6 soluble receptor in uremic patients. Kidney Int. 58:417–424. 2000. View Article : Google Scholar : PubMed/NCBI
5.	Qureshi AR, Alvestrand A, Divino-Filho JC, et al: Inflammation, malnutrition, and cardiac disease predictors of mortality in hemodialysis patients. J Am Soc Nephrol. 13:28–36. 2002.PubMed/NCBI
6.	Schiffrin EL, Lipman ML and Mann JF: Chronic kidney disease: effects on the cardiovascular system. Circulation. 116:85–97. 2007. View Article : Google Scholar : PubMed/NCBI
7.	Collins AJ: Cardiovascular mortality in end-stage renal disease. Am J Med Sci. 325:163–167. 2003. View Article : Google Scholar : PubMed/NCBI
8.	Silva LS, Oliveira RA, Silva GB, et al: Cardiovascular disease in patients with end-stage renal disease on hemodialysis in a developing country. Kidney Dis Transpl. 23:262–266. 2012.PubMed/NCBI
9.	Cozzolino M, Brancaccio D, Gallieni M and Slatopolsky E: Pathogenesis of vascular calcification in chronic kidney disease. Kidney Int. 68:429–436. 2005. View Article : Google Scholar : PubMed/NCBI
10.	Levin A: Anemia and left ventricular hypertrophy in chronic kidney disease populations: a review of the current state of knowledge. Kidney Int Suppl. 80:35–38. 2002. View Article : Google Scholar : PubMed/NCBI
11.	Memoli B, Minutolo R, Bisesti V, et al: Changes of serum albumin and C-reactive protein are related to changes of interleukin-6 release by peripheral blood mononuclear cells in hemodialysis patients treated with different membranes. Am J Kidney Dis. 39:266–273. 2002. View Article : Google Scholar
12.	Memoli B, Salerno S, Procino A, et al: A translational approach to micro-inflammation in end-stage renal disease: molecular effects of low levels of interleukin-6. Clin Sci (Lond). 119:163–174. 2010. View Article : Google Scholar
13.	Fumeron C, Nguyen-Khoa T, Saltiel C, et al: Effects of oral vitamin C supplementation on oxidative stress and inflammation status in haemodialysis patients. Nephrol Dial Transplant. 20:1874–1879. 2005. View Article : Google Scholar : PubMed/NCBI
14.	Fakhrzadeh H, Poorebrahim R, Shooshtarizadeh P, Raza M and Hosseini S: The effects of consumption of omega3 fatty acid-enriched eggs on insulin and CRP. Nutr Metab Cardiovasc Dis. 15:329–330. 2005. View Article : Google Scholar : PubMed/NCBI
15.	Madsen T, Schmidt EB and Christensen JH: The effect of n-3 fatty acids on C-reactive protein levels in patients with chronic renal failure. J Ren Nutr. 17:258–263. 2007. View Article : Google Scholar : PubMed/NCBI
16.	Taziki O, Lessan-Pezeshki M, Akha O and Vasheghani F: The effect of low dose omega-3 on plasma lipids in hemodialysis patients. Saudi J Kidney Dis Transpl. 18:571–576. 2007.PubMed/NCBI
17.	Micallef MA, Munro IA and Garg ML: An inverse relationship between plasma n-3 fatty acids and C-reactive protein in healthy individuals. Eur J Clin Nutr. 63:1154–1156. 2009. View Article : Google Scholar : PubMed/NCBI
18.	Liepa GU and Basu H: C-reactive proteins and chronic disease: what role does nutrition play? Nutr Clin Pract. 18:227–233. 2003. View Article : Google Scholar : PubMed/NCBI
19.	Magee P, Pearson S and Allen J: The omega-3 fatty acid, eicosapentaenoic acid (EPA), prevents the damaging effects of tumour necrosis factor (TNF)-alpha during murine skeletal muscle cell differentiation. Lipids Health Dis. 7:242008. View Article : Google Scholar : PubMed/NCBI
20.	Zoccali C, Mallamaci F and Tripepi G: Novel cardiovascular risk factors in end-stage renal disease. J Am Soc Nephrol. 15(Suppl 1): 77–80. 2004. View Article : Google Scholar : PubMed/NCBI
21.	Jabs WJ, Theissing E, Nitschke M, et al: Local generation of C-reactive protein in diseased coronary artery venous bypass grafts and normal vascular tissue. Circulation. 108:1428–1431. 2003. View Article : Google Scholar : PubMed/NCBI
22.	Devereux RB, Alonso DR, Lutas EM, et al: Echocardiographic assessment of left ventricular hypertrophy:comparison to necropsy findings. Am J Cardiol. 57:450–458. 1986. View Article : Google Scholar : PubMed/NCBI
23.	Lee S, Kim IT, Park HB, et al: High-sensitivity C-reactive protein can predict major adverse cardiovascular events in Korean patients with type 2 diabetes. J Korean Med Sci. 26:1322–1327. 2011. View Article : Google Scholar : PubMed/NCBI
24.	Moubarak M, Jabbour H, Smayra V, et al: Cardiorenal syndrome in hypertensive rats: microalbuminuria, inflammation and ventricular hypertrophy. Physiol Res. 61:13–24. 2012.PubMed/NCBI
25.	Hohensinner PJ, Niessner A, Huber K, Weyand CM and Wojta J: Inflammation and cardiac outcome. Curr Opin Infect Dis. 24:259–264. 2011. View Article : Google Scholar